For long thought of as a net recipient of global health benefits, India is turning into a global healthcare provider. This will be a major pillar of its diplomacy in the years to come.
India began the first phase of the mass vaccination programme against Covid-19. Fortune India's photo team visited one session site in Gurugram where the campaign was in full swing.
For BBIL’s founder Krishna Ella, the roll-out of a made-in-India vaccine, Covaxin, is peppered with challenges. Two recent deals with Brazilian and American firms have now buoyed him.
